Event
Medra raises $52M Series A to build Physical AI Scientists for drug discovery
Evidence notes
- Series A led by Human Capital with participation from Lux Capital, Neo, NFDG, Catalio Capital Management, Menlo Ventures, 776, and Fusion Fund
- Funding supports team growth, partnership scaling, and construction of a large-scale autonomous lab planned for 2026
- Medra combines scientific AI with robotic execution to run experiments on standard laboratory tools and instruments
Company context
Medra builds autonomous robotic lab systems for life-sciences research. Its Physical AI Scientist platform combines robotic workcells, lab perception and scientific AI to run protocols, operate instruments and improve experiments across biology and chemistry workflows.
Context
- Company
- Medra
- Segment
- Lab Automation
- Event type
- Funding
- Added to Korthos
- Mar 15, 2026
- Geography
- San Francisco · United States